Ozempic lowers smoking and drinking urges
A comprehensive American study has shown that GLP-1 medications such as Ozempic can reduce the risk of addiction disorders related to alcohol, nicotine, opioids, and cocaine by up to 85%. This effect is achieved through their influence on the brain's reward centers. These findings are preliminary and require larger clinical trials to confirm their efficacy and safety in treating addiction beyond their current uses for diabetes and obesity.
articleDetails.fontSize.sizeحجم النص
تنويه: هذا ملخص تم إنشاؤه بواسطة الذكاء الاصطناعي
comments.heading